CD25 (IL2RA) Orchestrates Negative Feedback Control and Stabilizes Oncogenic Signaling Strength in Acute Lymphoblastic Leukemia

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Blood

• Publication date

  2015-12-03

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD.V126.23.1434.1434
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Kidins220 regulates the development of B cells bearing the λ light chain

  2024cites this paper
• The emerging scenario of immunotherapy for T-cell Acute Lymphoblastic Leukemia: advances, challenges and future perspectives

  2023influential citation
• Kidins220 regulates the development of B cells bearing the λ light chain

  2022cites this paper
• Studies of B cell development and V(D)J recombination

  2019cites this paper
• Clinical Effect of CD25 on the Prognosis of Diffuse Large B Cell Lymphoma with Secondary Central Nervous System Relapse

  2019cites this paper
• IL-2/IL-3 interplay mediates growth of CD25 positive acute myeloid leukemia cells.

  2018cites this paper
• The emerging role of anti‐CD25 directed therapies as both immune modulators and targeted agents in cancer

  2017cites this paper